Update on the mechanism of action of antiepileptic drugs

Epilepsia
B S Meldrum

Abstract

Novel antiepileptic drugs (AEDs) are thought to act on voltage-sensitive ion channels, on inhibitory neurotransmission or on excitatory neurotransmission. Two successful examples of rational AED design that potentiate GABA-mediated inhibition are vigabatrin (VGB) by irreversible inhibition of GABA-transaminase, and tiagabine (TGB) by blocking GABA uptake. Lamotrigine (LTG) prolongs inactivation of voltage-dependent sodium channels. The anticonvulsant action of remacemide (RCM) is probably largely due to blockade of NMDA receptors and prolonged inactivation of sodium channels induced by its desglycinated metabolite. Felbamate (FBM) apparently blocks NMDA receptors, potentiates GABA-mediated responses, blocks L-type calcium channels, and possibly also prolongs sodium channel inactivation. Similarly, topiramate (TPM) has multiple probable sites of action, including sodium channels, GABA receptors, and glutamate (AMPA) receptors. Gabapentin (GBP) apparently has a completely novel type of action, probably involving potentiation of GABA-mediated inhibition and possibly also inactivation of sodium channels. The therapeutic advantages of the novel AEDs are as yet only partially explained by our present understanding of their mechanisms...Continue Reading

References

Oct 1, 1992·Physiological Reviews·W A Catterall
May 1, 1991·Epilepsia·M K TickuR D Sofia
Apr 1, 1990·Canadian Journal of Physiology and Pharmacology·C ZonaM Avoli
Mar 1, 1995·Neuropharmacology·H LüddensP H Seeburg
Jan 1, 1995·Epilepsy Research·H S WhiteH H Wolf
Jul 1, 1995·Journal of Neurochemistry·R A Waniewski, D L Martin
Oct 14, 1994·European Journal of Pharmacology·L A BordenC Gluchowski
May 17, 1994·European Journal of Pharmacology·F A TavernaJ F MacDonald
Nov 15, 1993·European Journal of Pharmacology·R J ThurlowG N Woodruff
Feb 15, 1993·European Journal of Pharmacology·D R HillG N Woodruff
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T J TurnerK Dunlap
Jan 1, 1996·Annals of Neurology·O A PetroffR H Mattson
Oct 1, 1995·British Journal of Pharmacology·A PisaniP Calabresi
Jun 20, 1996·European Journal of Pharmacology·A StefaniG Bernardi

❮ Previous
Next ❯

Citations

Jun 22, 1999·Journal of Neuroscience Research·D B JacobyJ Dinsmore
Jun 24, 2008·Purinergic Signalling·Ashwin KumariaGeoffrey Burnstock
Sep 17, 2002·Current Psychiatry Reports·Edward Kim
May 13, 2005·Neurochemistry International·Marc YudkoffItzhak Nissim
Feb 11, 2004·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Marc YudkoffItzhak Nissim
Jun 23, 2000·Biological Psychiatry·S L McElroyR M Post
Apr 20, 2000·European Journal of Pharmacology·G De SarroA De Sarro
Jul 6, 2000·European Journal of Pharmacology·M SwiaderS J Czuczwar
Oct 28, 1998·Journal of Psychiatric Research·A ErfurthJ Walden
Oct 26, 2000·Clinical Therapeutics·A A Ballasiotes, T L Skaer
Jul 13, 2001·Pharmacology & Therapeutics·P KwanM J Brodie
Jun 7, 2003·Brain Research. Brain Research Reviews·R R Leker, M Y Neufeld
Oct 28, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·A Erfurth, H Grunze
Feb 13, 2001·Progress in Neurobiology·D CentonzeP Calabresi
Jul 27, 2001·Neurologic Clinics·S C Schachater
Oct 6, 2001·Pediatric Neurology·A Di Martino, R F Tuchman
Aug 2, 2002·Epilepsy Research·David J MuzinaJoseph R Calabrese
Aug 8, 1998·Epilepsy Research·H R PouretemadP B Fenwick
Sep 21, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·F PlacidiG L Gigli
Aug 24, 2005·Nature Medicine·Guo-Feng TianMaiken Nedergaard
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Petra BittigauChrysanthy Ikonomidou
Jun 23, 2005·Epilepsia·Emilio Perucca
Apr 4, 1998·Pharmacology & Toxicology·M R KanyonyoD M Lambert
Feb 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·G L KraussN R Miller
Jun 18, 2009·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Benedikt AmannHarald Hampel
Oct 25, 2012·Neuropsychiatric Disease and Treatment·Frank Mc Besag, Philip N Patsalos
Apr 24, 2014·Journal of Ethnopharmacology·Ben A ChindoAxel Becker
Jun 11, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C SolaroG L Mancardi
Jul 29, 1998·Neuropharmacology·A StefaniG Bernardi
Oct 8, 1997·Journal of Clinical Psychopharmacology·J S MarkowitzW H Carson
Oct 2, 2003·Journal of Clinical Psychopharmacology·Terence A KetterRobert M Post
Jul 23, 1999·Annals of the New York Academy of Sciences·J R Stevens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.